Aktie A3DB90 CINCOR PHARMA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen CinCor Pharma, Inc.

Aktien

A3DB90

US17240Y1091

CINC

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Acquisition of CinCor Pharma complete
AstraZeneca Completes $1.8 Billion Acquisition of CinCor Pharma to Boost Cardiorenal Portfolio
AstraZeneca closes CinCor buy; Enhertu wins Chinese approval
AstraZeneca : acquisition de CinCor finalisée
CinCor Pharma : Acquisition/Asset Disposal - Form 8-K
CINCOR PHARMA, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from NASDAQ Composite Index
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from S&P Global BMI Index
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from S&P TMI Index
CinCor Pharma, Inc.(NasdaqGM:CINC) dropped from NASDAQ Biotechnology Index
Astrazeneca Finance And Holdings Inc. completed the acquisition of CinCor Pharma, Inc. from a group of shareholders.
CINCOR PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
CinCor Pharma, Inc. Announces Completion of End-of-Phase 2 Meeting with U.S. Food and Drug Administration on Anticipated Phase 3 Program for Baxdrostat in Hypertension
4 minutos de mercados : Febrero 9-2023
4 minutos de mercados : Febrero 8-2023
4 minutos de mercados : Febrero 7-2023
4 minutos de mercados : Febrero 6-2023
4 minutos de mercados : Febrero 3-2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DB90 Aktie
  4. Nachrichten CinCor Pharma, Inc.
  5. Andere Sprachen